CIK 0001000694 · Large accelerated filer
NOVAVAX INC
Sign in to watch- Ticker
- NVAX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 222816046
- Phone
- 240-268-2000
- Business address
- 21 FIRSTFIELD RD, GAITHERSBURG, MD
- 8-K Event Material agreement
- CORRESP Other Correspondence Between Filers and SEC Staff
- 4 Insider Changes in Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- SC 13D/A Stake Beneficial Ownership Report
- 424B5 Offering Prospectus
- 8-K Event Material agreement
- CORRESP Other Correspondence Between Filers and SEC Staff
- 8-K Event Other events
- 8-K Event Material agreement
- SC 13D/A Stake Beneficial Ownership Report
- 8-K Event Material agreement
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4/A Insider Changes in Ownership
- 4/A Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4/A Insider Changes in Ownership
- SC 13D/A Stake Beneficial Ownership Report
Page 71 of 83 · 1,649 filings